In an era of volatile markets, investors are increasingly seeking stable, predictable income streams. Capital Prudential is ...

Neuren Pharmaceuticals (ASX:NEU) is focused on neurodevelopmental disorders and rare disease drug development.

INOVIQ (ASX:IIQ) is developing and commercialising next-generation diagnostics and therapeutics focused on exosome-based ...

Island Pharmaceuticals (ASX: ILA) announced it has successfully raised $2.72 million through the exercise of listed options ...

North Stawell Minerals has announced the intersection of visible gold at its Darlington Project in Victoria, located within ...

Trigg Minerals (ASX: TMG) has announced a binding agreement to acquire 100% rights to the Nundle, Upper Hunter, and ...

RocketBoots Limited announced the successful completion of a major customer trial of its loss prevention software across ...

Google has signed a definitive agreement to acquire Wiz, a New York-based cloud security startup, for $32 billion in an ...

Cyclopharm Limited (CYC) is experiencing a period of significant growth, primarily driven by its Technegas technology. The ...

Tesla’s stock dropped 5.34% on Tuesday, falling to $225.31, as concerns about increasing competition from China’s BYD, ...

Short sellers have made $16.2 billion (A$25.5 billion) in profits over the past three months as Tesla’s share price has plummeted by more than 50%. Since 17 December 2024, the company’s market value ...

The Trim Capital Group is an independent Australian advisory and asset management firm specialising in corporate advisory, equities, and private lending.